OssDsign AB
5J6
Company Profile
Business description
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the USA.
Contact
Rapsgatan 23 A
Uppsala75450
SWESector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
32
Stocks News & Analysis
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
stocks
Bookworm: Is this the secret to exceptional long-term returns?
Acceptance may be an investor’s best friend.
stocks
Unconventional wisdom: Are dividends the answers?
As investors toil in complexity the obvious solution may be the right one.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,963.80 | 29.50 | 0.33% |
| CAC 40 | 7,834.58 | 16.30 | 0.21% |
| DAX 40 | 24,217.50 | 78.43 | -0.32% |
| Dow JONES (US) | 44,901.92 | 208.01 | 0.47% |
| FTSE 100 | 9,120.31 | 18.06 | -0.20% |
| HKSE | 25,388.35 | 278.83 | -1.09% |
| NASDAQ | 21,108.32 | 50.36 | 0.24% |
| Nikkei 225 | 41,221.43 | 234.80 | -0.57% |
| NZX 50 Index | 12,939.00 | 85.54 | 0.67% |
| S&P 500 | 6,388.64 | 25.29 | 0.40% |
| S&P/ASX 200 | 8,696.30 | 29.40 | 0.34% |
| SSE Composite Index | 3,593.03 | 0.62 | -0.02% |